product summary
Loading...
company name :
Sino Biological
product type :
protein
product name :
Human Sonic Hedgehog/SHH Protein (C25I)
catalog :
10372-HNAE
quantity :
100 µg
price :
348 USD
more info or order :
Sino Biological product webpage
product information
Catalog Number :
10372-HNAE
Product Name :
Human Sonic Hedgehog/SHH Protein (C25I)
Product Type :
Protein
Host Species :
E. coli
Conjugation :
Native
Size :
100 µg
List Price :
348 USD
Product Description :
A DNA sequence encoding the Human Sonic Hedgehog/SHH (Q15465) (Cys24-Gly197) was expressed.
SpeciesSummary :
Human
ALTnames :
SHH,HHG1,HLP3,HPE3,MCOPCB5,ShhNC,SMMCI,TPT
Purity :
≥ 95 % as determined by SDS-PAGE.
Buffer :
Lyophilized from sterile PBS, pH 7.4.
Packaging :
In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature. Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
Storage :
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
more info or order :
Sino Biological product webpage
company information
Sino Biological
Building 9, No.18 Kechuang 10th St, BDA, Beijing, 100176
marketing@sinobiological.com
https://www.sinobiological.com
86 400-890-9989
headquarters: China
Sino Biological is an international reagent supplier and service provider. The company specializes in recombinant protein production and antibody development. All of Sino Biological's products are independently developed and produced, including recombinant proteins, antibodies and cDNA clones. Sino Biological is the researchers' one-stop technical services shop for the advanced technology platforms they need to make advancements. In addition, Sino Biological offer pharmaceutical companies and biotechnology firms pre-clinical production technology services for hundreds of monoclonal antibody drug candidates.